PYRAZINAMIDE (Z), 400mg, tab., blister
Valid Article
OC subscriptions: included in supply or field order tools (e.g. UniField)
|
|
SC subscriptions: included in supply or field tools
|
|
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
|
|
PYRAZINAMIDE (Z)
Therapeutic Action
Antituberculosis bactericide
Indications
Drug-Resistant Tuberculosis (DR-TB), in combination with other TB medicines
Drug-Sensitive Tuberculosis (DS-TB)
Instructions for use
The 150 mg dispersible tablet is intended for paediatric use. To be dispersed in 10 ml water.
When pyrazinamide is used in association with other TB medicines, fixed-dose combinations (FDC) are available:
- E 275mg / H 75mg / Z 400mg / R 150mg, tab., blister
- H 50mg / Z 150mg / R 75mg, disp. tab., blister
Blister packaging is the packaging of choice for antituberculosis medicines due to the unstable nature of some of them when exposed to higher temperatures and humidity.
Bulk packaging (hospital packs) should only be used in special circumstances or in case of unexpected problems in availability of the blister presentation.
The quantity to be ordered is calculated per tablet, not per blister.
Storage
Below 25°C ‐ Protect from sunlight ‐ Protect from humidity